United-Guardian, Inc. (UG) is a publicly traded Consumer Defensive sector company. As of November 9, 2026, UG trades at $8.19 with a market cap of $30.83M and a P/E ratio of 13.18. UG moved +21.16% today. Year to date, UG is +8.93%; over the trailing twelve months it is -4.14%. Its 52-week range spans $5.58 to $10.09. Rallies surfaces UG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
United-Guardian Q3 sales rise 54% to $3.49 million as Renacidin and cosmetic ingredients grow: United-Guardian’s third-quarter 2026 net income more than tripled to $930,912, and net sales rose 54% to $3.49 million. Pharmaceutical, cosmetic ingredient and medical lubricant sales grew; the company plans new Renacidin marketing efforts and expects to launch a personal care product early next year.
| Metric | Value |
|---|---|
| Price | $8.19 |
| Market Cap | $30.83M |
| P/E Ratio | 13.18 |
| EPS | $0.54 |
| Dividend Yield | 0.30% |
| 52-Week High | $10.09 |
| 52-Week Low | $5.58 |
| Volume | 45.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.21M |
| Net Income | $2.47M |
| Gross Margin | 46.90% |
UG analyst coverage data. Average price target: $0.00.